La JollaManufacturingBiotechnologyHealthcareHardwareFinancial ServicesFinanceFintechLendingBanking
Description
Ensysce Biosciences has announced a significant transition in its executive leadership. Following the upcoming Annual Meeting on December 14, 2026, Dr. Lynn Kirkpatrick will step down as CEO and assume the role of Chief Operating Officer
Who to call at Ensysce Biosciences, and when
A new leader at Ensysce Biosciences brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Ensysce Biosciences raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Ensysce Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ensysce Biosciences. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Ensysce Biosciences
Location
7946 IVANHOE AVE
La Jolla, California, United States
About
Ensysce Biosciences, Inc. (NASDAQ: ENSC) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ensysce Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
La JollaManufacturingBiotechnologyHealthcareHardwareFinancial ServicesFinanceFintechLendingBanking